openPR Logo
Press release

Cardiac Biomarker Diagnostic Test Kits Market to reach US$ 2,540.8 Mn| Competitive Strategies and Forecast 2018-2028

03-01-2019 12:58 PM CET | Health & Medicine

Press release from: future market insights.

Cardiac Biomarker Diagnostic Test Kits Market to reach US$

According to the latest market report published by the company titled ‘Global Cardiac Biomarker Diagnostic Test Kits: Global Industry Analysis 2013–2017 and Opportunity Assessment, 2018–2028’, the global cardiac biomarker diagnostic test kits market is projected to expand at a CAGR of 5.1% during the forecast period 2018–2028 and reach US$ 2,540.8 Mn by the end of 2028.

Global Cardiac Biomarker Diagnostic Test Kits Market: Dynamics

Chest pain is a common emergency department (ED) presentation accounting for 8–10 million visits per year in the U.S. The increasing number of patient visits in the emergency department is expected to create growth opportunities for the cardiac biomarker diagnostic test kits market. Obesity has become a global health challenge in the past few decades, with every sixth person being obese. According to the WHO, the number of obese population around the globe has doubled in the last two decades. The growing obese population, which is at a high risk of developing cardiovascular diseases, is expected to consequently increase the demand for cardiac biomarker diagnostic test kits. Moreover, the leading manufacturers of cardiac biomarker diagnostic test kits are focusing on collaborating with universities and associations to develop and expand their product portfolio. On the other hand, less availability of novel cardiac biomarker diagnostic test kits due to tedious approval procedures is expected to hamper the growth of the cardiac biomarker diagnostic test kits market over the next decade.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-452

Global Cardiac Biomarker Diagnostic Test Kits Market: Forecast

The global cardiac biomarker diagnostic test kits market is segmented on the basis of product type, indication, end users and regions. On the basis of product type, the cardiac biomarker diagnostic test kits market has been segmented into Brain Natriuretic Peptide (BNPs) Test Kits, Creatine Kinase MB (CK-MB) Test Kits, Troponin (I&T) Tests Kits, Myoglobin Test Kits and other test kits. By product type, the BNP test kits segment dominated the global cardiac biomarker diagnostic test kits market with market value of US$ 682.9 Mn in 2017, and is expected to be the most lucrative segment throughout the forecast period. The BNP test kits segment in the global cardiac biomarker diagnostic test kits market is also projected to be the fast-growing segment, and to grow at CAGR of 6.8% over 2018–2028.

On the basis of indication, the cardiac biomarker diagnostic test kits market is segmented into Angina Pectoris, Acute Myocardial Infarction, Congestive Heart Failure, and others. By indication, the Angina Pectoris is expected to be the most lucrative segment in the cardiac biomarker diagnostic test kits market, and is estimated to account 45.2% value share in 2018 and to account for 41.4% value share by 2028 end, growing at a CAGR of 3.6%. The congestive heart failure segment by indication is expected to be the fast-growing segment in the cardiac biomarker diagnostic test kits market. The congestive heart failure segment is projected to grow at a CAGR of 6.7% over the forecast period to reach a market value of US$ 357.8 Mn by 2028.

On the basis of end users, the cardiac biomarker diagnostic test kits market has been segmented into hospitals, diagnostic laboratories, outpatient clinics, academic and research institutes. The diagnostic laboratories segment is expected to dominate the global cardiac biomarker diagnostic test kits market in 2018 as a large number of patients visit diagnostic laboratories for the diagnosis of cardiovascular disease. Revenue from the diagnostic laboratories segment is expected to increase at a CAGR of 5.9% over 2018–2028, to reach US$ 997.4 Mn by 2028.

On the basis of region, the cardiac biomarker diagnostic test kits market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, China, Japan and Middle East & Africa. North America dominated the global cardiac biomarker diagnostic test kits market with maximum value share in 2017. Chest pain is a common emergency department (ED) presentation in the region accounting for 8–10 million visits per year in the U.S., among which 20% of patients are diagnosed with the help of cardiac biomarker diagnostic test kits for cardiovascular diseases. One-third share of the cardiac biomarker diagnostic test kits market by value is accounted by the U.S. due to increasing prevalence of cardiovascular diseases and rising adoption of cardiac biomarker diagnostic test kits. APECJ is expected to be the fast-growing regional markets for cardiac biomarker diagnostic test kits due to increasing number of obese population and expansion strategies followed by the key manufacturers in the region. Latin America and MEA are expected to witness sluggish growth in the global cardiac biomarker diagnostic test kits market due to low awareness regarding the benefits of cardiac biomarker diagnostic test kits for the diagnosis of cardiovascular diseases.

Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-452

Global Cardiac Biomarker Diagnostic Test Kits Market: Competitive Landscape

Examples of some of the key players operating in the global cardiac biomarker diagnostic test kits market are Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Siemens AG, bioMérieux SA, Randox Laboratories Ltd. The global cardiac biomarker diagnostic test kits market is highly fragmented, with top six players, estimated to account for approximately 75% market share. Abbott Laboratories accounted maximum share of the global cardiac biomarker diagnostic test kits market in 2017, due to the acquisition of Alere Inc., which has helped the company to expand its product portfolio. Acquisition is the key strategy followed by all the leading manufacturers of cardiac biomarker diagnostic test kits market to expand their business. The companies of cardiac biomarker diagnostic test kits market are focusing on acquiring local manufacturers to expand their product portfolio and also to increase their market share.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Future Market Insights
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: abhishek.b@futuremarketinsights.com
FMI Blog:  https://www.fmiblog.com/
Web: https://www.futuremarketinsights.com
Blog: http://www.marketresearchblog.org/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Biomarker Diagnostic Test Kits Market to reach US$ 2,540.8 Mn| Competitive Strategies and Forecast 2018-2028 here

News-ID: 1626645 • Views: 313

More Releases from future market insights.

Facial Implants Market 2018 - 2028 | Key Players Include Implatech Associates In …
Facial implants are a type of medical device used to correct the facial structure or to provide more defined facial features including cheeks or chin & jawline. Facial Implants products are used for cosmetic reasons & are also used in medical crises such as accidents and injuries. Facial implants are also designed for augmentative or reconstructive surgeries. Facial implants give long lasting and permanent results that are a key factor
Pericarditis Treatment Market 2018 - 2028 | Pfizer Inc., Bayer AG, PerkinElmer I …
Global Pericarditis Treatment: Market Insights  Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other causes of pericarditis disease are renal failure, bacterial infections and intake of some drugs such as procainamide. Some of the common symptoms of pericarditis disease are shortness of breath, fatigue, rapid
Aldosteronism Treatment Market Drivers and Restraints | 2018 - 2028 Key Players …
Aldosteronism is a type of hormonal disorder that occurs due to an imbalance in aldosterone and further leads to high blood pressure. In Aldosteronism, aldosterone is produced in excess by the adrenal gland that exceeds the normal body requirement. This causes the sodium levels to increase and lowers the potassium levels in the body. High levels of sodium in the blood lead to a high volume of blood and ultimately
Contouring Implants Market 2018 - 2028 | Key Players are ALPHA-HEALTH (ASIA) PTE …
Body Contouring refers to the medical-surgical procedure that alternates the shape of parts of the body via the removal of fat or skin. Body contouring implants procedures includes reshaping and resizing certain areas so the persons overall appearance is more balanced and in proportion. Body contouring implants are foreign materials that is made and molded prior to the person’s surgery and then inserted into the appropriate site. The body contouring

All 5 Releases


More Releases for Test

Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption
Global Mechanical Test Equipment Industry Global Mechanical Test Equipment Indus …
This study focuses on the production side and consumption side of Mechanical Test Equipment, presents the global Mechanical Test Equipment market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025. In terms of production side, this report researches the Mechanical Test Equipment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type. In terms of
Test Automation Market
Test automation is being utilized in software for comparing the tangible outcomes with expected software outcomes. Automatically, there are various tools that help in operation of controlling the test execution. Software testing which is done manually through which person operates on the computer and go through several stages needed for testing purpose such as trying various usage, application screens, and input combinations that compares the results to be projected behavior
Test Series for Gate
As the market is not only based on talent any more but demands smart brains scoring stupendous. As just being a graduate from a simple or less renowned college does not make you stand in the market that demands highly educated and professional citizens people are switching themselves for higher education to reputed university and the entrance gate for reputed colleges are only through exams like GATE. People are spending
immigration DNA Test In
Immigration Dna Test in India Advanced DNA offer Paternity, Maternity, Siblings, Immigration Dna Test etc. in India. We offer a wide range of testing methods available for establishing a biological relationship for immigration, which include both paternity, and maternity testing. However other relationships can be proved between Siblings, Aunts/Uncles, Nieces/Nephews and Grandparents through our Relationship Testing. What Is The Process I Need To Follow for an Immigration Test? Advanced DNA India our Immigration department
itelligence wins ERP test
SAP consulting house wins first place Bielefeld (Germany), June 12, 2009 – In a comparison for ERP systems, GPS Gesellschaft für Prüfung von Software mbH and MQ result consulting AG tested the state of technology for 2009. With its it.manufacturing solution, the SAP consulting house itelligence won first place in multi-site solutions for ERP systems with the best rating – both from the technical jury as well as from the public. On